Back to Evidence
Paper-scoped peptide mentionSequence reported

R18D

PMC13239245::PEP000001

Source publication

Pharmacokinetics and Neuroprotective Efficacy of Poly‐Arginine Peptide R18D in Sprague Dawley Rats Subjected to Transient Intraluminal Filament Middle Cerebral Artery Occlusion Stroke

CNS Neuroscience & Therapeutics · 2026

Sequence status
reported
Standardization
Sequence ready
Source location
unknown
Activity records
27

Sequence evidence

Reported molecular identity

RRRRRRRRRRRRRRRRRR

Section 2.1: R18D peptide, also known as ARG‐007 (H‐rrrrrrrrrrrrrrrrrr‐OH; lower case letters represent D‐arginine) was synthesized by Auspep.

Resolved peptide links

Experimental observations

Records linked to this mention

Metabolic/CardiovascularAntibacterialPositive observation
Record detail

Table 1: R18D 325 nmol/kg reduced infarct volume by 47.2% (p=0.0003). Total infarct volume 149.4 ± 70.05 mm3 vs Vehicle Saline 283.09 ± 50.28 mm3.

Measure
percent_inhibition
Value
47.2%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
Metabolic/CardiovascularAntibacterialPositive observation
Record detail

Table 1: R18D 650 nmol/kg reduced infarct volume by 28.4% (p=0.008). Total infarct volume 202.6 ± 64.94 mm3 vs Vehicle Saline 283.09 ± 50.28 mm3.

Measure
percent_inhibition
Value
28.4%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
Metabolic/CardiovascularAntibacterialPositive observation
Record detail

Table 1: R18D 1100 nmol/kg reduced infarct volume by 27.9% (p=0.003). Total infarct volume 204.1 ± 48.26 mm3 vs Vehicle Saline 283.09 ± 50.28 mm3.

Measure
percent_inhibition
Value
27.9%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
Metabolic/CardiovascularAntibacterialPositive observation
Record detail

Table 1 and text: R18D 325 nmol/kg reduced hemisphere swelling by 5.6% (p=0.15). Hemisphere swelling 108.29 ± 10.53% vs Vehicle Saline 114.76 ± 7.36%.

Measure
percent_inhibition
Value
5.6%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
Metabolic/CardiovascularAntibacterialPositive observation
Record detail

Table 1 and text: R18D 650 nmol/kg reduced hemisphere swelling by 8.3% (p=0.01). Hemisphere swelling 105.26 ± 7.23% vs Vehicle Saline 114.76 ± 7.36%.

Measure
percent_inhibition
Value
8.3%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
Metabolic/CardiovascularAntibacterialPositive observation
Record detail

Table 1 and text: R18D 1100 nmol/kg reduced hemisphere swelling by 4.5% (p=0.14). Hemisphere swelling 109.56 ± 7.25% vs Vehicle Saline 114.76 ± 7.36%.

Measure
percent_inhibition
Value
4.5%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
ToxicityGeneral ToxicPositive observation
Record detail

Table 2: R18D 325 nmol/kg group had 7.35% body weight loss from baseline (Day 0 to Day 1). Vehicle Saline group had 9.35% loss.

Measure
percent_inhibition
Value
7.35%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
ToxicityGeneral ToxicPositive observation
Record detail

Table 2: R18D 650 nmol/kg group had 10.62% body weight loss from baseline (Day 0 to Day 1). Vehicle Saline group had 9.35% loss.

Measure
percent_inhibition
Value
10.62%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
ToxicityGeneral ToxicPositive observation
Record detail

Table 2: R18D 1100 nmol/kg group had 9.97% body weight loss from baseline (Day 0 to Day 1). Vehicle Saline group had 9.35% loss.

Measure
percent_inhibition
Value
9.97%
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
OtherPositive observation
Record detail

Table 3: R18D 650 nmol/kg Cmax 11,977 ng/mL. Table footnote: Cmax observed 10 min after start of infusion for 650 and 1100 nmol/kg doses.

Measure
other
Value
11,977 ng/mL
Target
Rattus norvegicus
Assay
Not reported by source
Source publication
OtherPositive observation
Record detail

Table 3: R18D 1100 nmol/kg Cmax 17,313 ng/mL. Table footnote: Cmax observed 10 min after start of infusion for 650 and 1100 nmol/kg doses.

Measure
other
Value
17,313 ng/mL
Target
Rattus norvegicus
Assay
Not reported by source
Source publication

Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.